3VHEALTHCARE_LIMITED - Accounts


Company Registration No. 6733977 (England and Wales)
3VHEALTHCARE LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2018
PAGES FOR FILING WITH REGISTRAR
3VHEALTHCARE LIMITED
CONTENTS
Page
Balance sheet
1 - 2
Notes to the financial statements
3 - 8
3VHEALTHCARE LIMITED
BALANCE SHEET
AS AT 31 MARCH 2018
31 March 2018
- 1 -
2018
2017
Notes
£
£
£
£
Fixed assets
Tangible assets
3
48,768
61,513
Current assets
Debtors
4
57,203
45,936
Cash at bank and in hand
80,520
144,119
137,723
190,055
Creditors: amounts falling due within one year
5
(49,428)
(81,218)
Net current assets
88,295
108,837
Total assets less current liabilities
137,063
170,350
Creditors: amounts falling due after more than one year
6
-
(5,332)
Provisions for liabilities
(4,000)
(6,000)
Net assets
133,063
159,018
Capital and reserves
Called up share capital
7
900
900
Profit and loss reserves
132,163
158,118
Total equity
133,063
159,018

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

For the financial year ended 31 March 2018 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime.

3VHEALTHCARE LIMITED
BALANCE SHEET (CONTINUED)
AS AT 31 MARCH 2018
31 March 2018
- 2 -
The financial statements were approved by the board of directors and authorised for issue on 12 September 2018 and are signed on its behalf by:
Dr J Douglas
Dr R Edwards
Dr J Holderness
Director
Director
Director
Company Registration No. 6733977
3VHEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2018
- 3 -
1
Accounting policies
Company information

3VHealthcare Limited is a private company limited by shares incorporated in England and Wales. The registered office is 3Mc Middlemarch Business Park, Siskin Drive, Coventry, CV3 4FJ.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention, modified to include the revaluation of freehold properties and to include investment properties and certain financial instruments at fair value. The principal accounting policies adopted are set out below.

1.2
Turnover

Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.

 

When cash inflows are deferred and represent a financing arrangement, the fair value of the consideration is the present value of the future receipts. The difference between the fair value of the consideration and the nominal amount received is recognised as interest income.

Revenue from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have passed to the buyer (usually on dispatch of the goods), the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the entity and the costs incurred or to be incurred in respect of the transaction can be measured reliably.

Revenue from contracts for the provision of professional services is recognised by reference to the stage of completion when the stage of completion, costs incurred and costs to complete can be estimated reliably. The stage of completion is calculated by comparing costs incurred, mainly in relation to contractual hourly staff rates and materials, as a proportion of total costs. Where the outcome cannot be estimated reliably, revenue is recognised only to the extent of the expenses recognised that it is probable will be recovered.

1.3
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Leasehold improvements
Nil
Plant and machinery
10% on cost
Computer equipment
20% on cost

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

3VHEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2018
1
Accounting policies
(Continued)
- 4 -
1.4
Impairment of fixed assets

At each reporting period end date, the company reviews the carrying amounts of its tangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.

Recoverable amount is the higher of fair value less costs to sell and value in use. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset for which the estimates of future cash flows have not been adjusted.

 

If the recoverable amount of an asset (or cash-generating unit) is estimated to be less than its carrying amount, the carrying amount of the asset (or cash-generating unit) is reduced to its recoverable amount. An impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the impairment loss is treated as a revaluation decrease.

Recognised impairment losses are reversed if, and only if, the reasons for the impairment loss have ceased to apply. Where an impairment loss subsequently reverses, the carrying amount of the asset (or cash-generating unit) is increased to the revised estimate of its recoverable amount, but so that the increased carrying amount does not exceed the carrying amount that would have been determined had no impairment loss been recognised for the asset (or cash-generating unit) in prior years. A reversal of an impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the reversal of the impairment loss is treated as a revaluation increase.

1.5
Cash at bank and in hand

Cash at bank and in hand are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.6
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

 

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

 

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

3VHEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2018
1
Accounting policies
(Continued)
- 5 -
Basic financial liabilities

Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

 

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

 

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

1.7
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of direct issue costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

1.8
Derivatives

Derivatives are initially recognised at fair value at the date a derivative contract is entered into and are subsequently remeasured to fair value at each reporting end date. The resulting gain or loss is recognised in profit or loss immediately unless the derivative is designated and effective as a hedging instrument, in which event the timing of the recognition in profit or loss depends on the nature of the hedge relationship.

 

A derivative with a positive fair value is recognised as a financial asset, whereas a derivative with a negative fair value is recognised as a financial liability.

1.9
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

 

The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.

3VHEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2018
1
Accounting policies
(Continued)
- 6 -
1.10
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.

 

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

 

Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

1.11
Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

1.12
Leases

Rentals payable under operating leases, including any lease incentives received, are charged to income on a straight line basis over the term of the relevant lease except where another more systematic basis is more representative of the time pattern in which economic benefits from the lease asset are consumed.

1.13
Government grants

Government grants are recognised at the fair value of the asset received or receivable when there is reasonable assurance that the grant conditions will be met and the grants will be received.

 

A grant that specifies performance conditions is recognised in income when the performance conditions are met. Where a grant does not specify performance conditions it is recognised in income when the proceeds are received or receivable. A grant received before the recognition criteria are satisfied is recognised as a liability.

2
Employees

The average monthly number of persons (including directors) employed by the company during the year was 13 (2017 - 9).

3
Tangible fixed assets
Leasehold improvements
Plant and machinery
Computer equipment
Total
£
£
£
£
Cost
At 1 April 2017 and 31 March 2018
24,886
97,595
14,934
137,415
Depreciation and impairment
At 1 April 2017
-
72,915
2,987
75,902
Depreciation charged in the year
-
9,758
2,987
12,745
At 31 March 2018
-
82,673
5,974
88,647
Carrying amount
At 31 March 2018
24,886
14,922
8,960
48,768
At 31 March 2017
24,886
24,680
11,947
61,513
3VHEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2018
- 7 -
4
Debtors
2018
2017
Amounts falling due within one year:
£
£
Trade debtors
42,642
29,879
Corporation tax recoverable
6,490
6,490
Prepayments and accrued income
8,071
9,567
57,203
45,936
5
Creditors: amounts falling due within one year
2018
2017
Notes
£
£
Corporation tax
4,635
-
Government grants
5,332
5,328
Accruals and deferred income
39,461
75,890
49,428
81,218
6
Creditors: amounts falling due after more than one year
2018
2017
Notes
£
£
Government grants
-
5,332
7
Called up share capital
2018
2017
£
£
Ordinary share capital
Issued and fully paid
300 Ordinary A of £1 each
300
300
300 Ordinary B of £1 each
300
300
300 Ordinary C of £1 each
300
300
900
900
3VHEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2018
- 8 -
8
Related party transactions
Transactions with related parties

During the year the company entered into the following transactions with related parties:

 

Sett Valley Medical Centre

A medical practice of which Dr J K Douglas is a partner.

 

During the year the company made payments for medical services, administration costs and reimbursement of expenses totalling £14,600 (2017 £7,800). All payments were made on a commercial basis and all amounts owing at the balance sheet date have since been paid and are included in the figures above.

 

Thornbrook Surgery

A medical practice of which Dr R N Edwards is a partner.

 

During the year the company made payments for medical services, administration costs and reimbursement of expenses totalling £18,968 (2017 £20,188). All payments were made on a commercial basis and all amounts owing at the balance sheet date have since been paid and are included in the figures above.

 

Goyt Valley Medical Practice

A medical practice of which Dr J A Holderness is a partner.

 

During the year the company made payments for medical services, administration costs and reimbursement of expenses totalling £15,129 (2017 £19,438). All payments were made on a commercial basis and all amounts owing at the balance sheet date have since been paid and are included in the figures above.

 

Specialist Community Skin Services Limited

A limited company of which Dr R N Edwards is a director.

 

During the year the company made payments for medical services, administration costs and reimbursement of expenses totalling £48,925 (2017 £nil). All payments were made on a commercial basis and all amounts owing at the balance sheet date have since been paid and are included in the figures above.

2018-03-312017-04-01falseCCH SoftwareCCH Accounts Production 2018.200No description of principal activity12 September 2018Dr J DouglasDr R EdwardsDr J HoldernessDr J Douglas67339772017-04-012018-03-3167339772018-03-3167339772017-03-316733977core:LeaseholdImprovements2018-03-316733977core:PlantMachinery2018-03-316733977core:ComputerEquipment2018-03-316733977core:LeaseholdImprovements2017-03-316733977core:PlantMachinery2017-03-316733977core:ComputerEquipment2017-03-316733977core:CurrentFinancialInstruments2018-03-316733977core:CurrentFinancialInstruments2017-03-316733977core:Non-currentFinancialInstruments2017-03-316733977core:ShareCapital2018-03-316733977core:ShareCapital2017-03-316733977core:RetainedEarningsAccumulatedLosses2018-03-316733977core:RetainedEarningsAccumulatedLosses2017-03-316733977core:ShareCapitalOrdinaryShares2018-03-316733977core:ShareCapitalOrdinaryShares2017-03-316733977bus:CompanySecretaryDirector12017-04-012018-03-316733977bus:Director12017-04-012018-03-316733977bus:Director22017-04-012018-03-316733977core:LeaseholdImprovementscore:LeasedAssetsHeldAsLessee2017-04-012018-03-316733977core:PlantMachinery2017-04-012018-03-316733977core:ComputerEquipment2017-04-012018-03-316733977core:LeaseholdImprovements2017-03-316733977core:PlantMachinery2017-03-316733977core:ComputerEquipment2017-03-3167339772017-03-316733977bus:OrdinaryShareClass12017-04-012018-03-316733977bus:OrdinaryShareClass22017-04-012018-03-316733977bus:OrdinaryShareClass32017-04-012018-03-316733977bus:OrdinaryShareClass12018-03-316733977bus:OrdinaryShareClass22018-03-316733977bus:OrdinaryShareClass32018-03-316733977bus:PrivateLimitedCompanyLtd2017-04-012018-03-316733977bus:FRS1022017-04-012018-03-316733977bus:AuditExemptWithAccountantsReport2017-04-012018-03-316733977bus:SmallCompaniesRegimeForAccounts2017-04-012018-03-316733977bus:Director32017-04-012018-03-316733977bus:CompanySecretary12017-04-012018-03-316733977bus:FullAccounts2017-04-012018-03-31xbrli:purexbrli:sharesiso4217:GBP